Top Drug Discovery and Development Companies in Europe
Nominate a Company
Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.
Top Drug Discovery and Development Companies in Europe
Drug Discovery and Development News
Development Expertise Becomes a Deciding Factor in European Pharmaceutical Outsourcing
Wednesday, August 12, 2026
A manufacturing agreement often begins long before production starts. Pharmaceutical companies developing generic medicines or biologic therapies increasingly spend more time evaluating scientific support than negotiating production schedules. The discussion has shifted toward one question: can a development partner solve technical issues before they become manufacturing problems? That change is influencing how European development service providers are selected. Manufacturing capacity remains relevant, but it is no longer enough on its own. Drug developers are paying closer attention to process development, analytical expertise and the ability to guide a product through differe
European Drug Developers Reassess Manufacturing Partnerships as Generic and Biopharmaceutical Pipelines Grow More Complex
Wednesday, August 12, 2026
Finding manufacturing support has become a more involved decision for pharmaceutical companies developing both generic medicines and biopharmaceutical products. What once centred on securing production capacity now extends much further. Companies are weighing whether a development partner can support a product from early process work through commercial manufacturing without creating unnecessary delays between stages. That shift is changing how development services are evaluated across Europe. Contract development and manufacturing organisations are no longer viewed simply as production facilities. Their involvement often begins while manufacturing processes are still being refin
European Development Providers Balance Capacity Expansion With Long-Term Scientific Investment
Wednesday, August 12, 2026
Adding manufacturing capacity is only one part of preparing for future pharmaceutical demand. European development organisations are also making decisions about technical expertise, specialised production platforms and scientific resources as generic medicines and biopharmaceutical products continue to expand across development pipelines. Facility expansion attracts attention because it increases manufacturing availability. Yet additional production suites alone do not guarantee that increasingly complex medicines can move efficiently from development into commercial manufacturing. The scientific capabilities supporting those facilities often determine how effectively new capaci
The Next Frontier in European Pharmaceutical Formulations
Friday, March 06, 2026
The European landscape for smart drug product formulation services is rapidly evolving, driven by the ever-increasing demand for sophisticated and patient-centric therapeutic solutions. This industry is characterised by a confluence of scientific advancements, regulatory developments, and a growing emphasis on personalised medicine, a key driver of innovation. The focus is shifting towards creating drug products that not only effectively deliver the active pharmaceutical ingredient (API) but also incorporate functionalities that enhance therapeutic outcomes, improve patient adherence, and offer greater convenience. Advancements in Drug Delivery Technologies
The Role of Computational Chemistry in Modern Drug Discovery
Monday, August 26, 2024
Computational chemistry, which uses computer simulations and calculations, is crucial for drug discovery, accelerating development, and fostering innovation. AI and machine learning enhance dataset analysis. FREMONT, CA: Computational chemistry, a discipline that leverages computer simulations and calculations to study chemical systems, has become vital in modern drug discovery. By offering detailed insights into molecular interactions, properties, and behaviours, computational methods transform the identification and optimisation of new drugs. In Europe, this technology accelerates drug development, addresses unmet medical needs, and foste
Harnessing Predictive Analytics and Big Data in Drug Development
Saturday, August 24, 2024
The pharmaceutical industry is leveraging big data and advanced analytics to optimise target identification, lead design, and adverse event prediction, supported by European initiatives like the Medicines Agency and Horizon Europe program. FREMONT, CA: The pharmaceutical industry is experiencing a transformative shift fueled by the convergence of big data and advanced analytics. These technologies are reshaping the entire drug development pipeline, from target identification to optimising clinical trials. In Europe, a region recognised for its scientific excellence and stringent regulatory standards, the adoption of predictive analytics is
